IMPase	inositol-monophosphatase
IPPase	inositol polyphosphate-1-phosphatase
GSK-3	glycogen-synthase-kinase-3
AD	Alzheimer’s disease
CNS	central nervous system
HD	Huntington’s disease
ALS	amyotrophic lateral sclerosis
sALS	sporadic ALS
fALS	familial ALS
FTLD	frontotemporal lobar dementia
PD	Parkinson’s disease
INNs	intraneuronal nuclear inclusions
HTT	huntingtin gene
CAG	cytosine–adenine–guanine
SNpc	substantia nigra pars compacta
LBs	Lewy bodies
CMA	chaperone-mediated autophagy
MS	Multiple sclerosis
RRMS	relapsing-remitting
SPMS	secondary progressive phase
PPMS	primary progressive disease
APP	amyloid-precursor protein
Aβ	amyloid beta
FDA	food and drug administration
IP3	inositol triphosphate
DAG	diacylglycerol
PHFs	paired helical filaments
Ach	acetylcholine
AChE	acetylcholinesterase
AChE-S	synaptic AChE
AChE-R	readthrough acetylcholinesterase
TBI	traumatic brain injury
BACE-1	β-secretase-1
PP2A	protein phosphatase 2A
PS1	presenilin-1
LiPQQ	tri-lithium pyrroloquinoline quinone
ABAD	β-amyloid-binding alcohol dehydrogenase
CREB1	cyclic AMP responsive element binding protein 1
CRTC1	transcriptional coactivator for CREB1
Bace1	β-site APP cleaving enzyme-1
CSF	cerebrospinal fluid
BDNF	brain-derived neurotrophic factor
GDNF	glial cell-derived neurotrophic factor
PKC	protein kinase C
NDI	nephrogenic diabetes insipidus
CKD	chronic kidney disease
ESKD	end-stage kidney disease
LRP1	lipoprotein receptor-related protein 1